ASTEC718.10

Astec LifeSciences Limited

· Chemicals
AnnualQuarterly₹ CrorePeersPUNJABCHEMMOLIPLINSECTICIDDHARMAJBHARATRASADVANCEHERANBAMcap ₹1,600 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue from Operations458.2381.3448.1440.6
Other Income5.65.65.15.3
Total Income463.8386.9453.2445.9
Expenses
+ Cost of Materials Consumed318.8248.9270.5287.4
+ Changes in Inventories0.548.128.0-10.2
+ Employee Benefit Expense61.761.162.963.7
+ Finance Costs25.236.734.531.2
+ Depreciation & Amortisation36.343.744.944.5
+ Other Expenses83.189.591.394.0
Total Expenses525.6527.9532.1510.5
EBITDA-5.9-66.2-4.55.8
EBIT-42.2-109.9-49.4-38.7
Profit
PBT before Exceptional Items-61.7-141.0-78.9-64.6
+ Exceptional Items0.00.0-2.1-2.1
Pretax Income-61.7-141.0-81.0-66.7
+ Current Tax0.00.00.00.0
+ Deferred Tax-14.9-6.3-0.2-0.2
Tax Expense-14.9-6.3-0.1-0.2
Net Income-46.9-134.7-80.9-66.6
+ Net Income — Continuing Ops-46.9-134.7-80.9-66.6
+ Other Comprehensive Income-0.60.20.50.5
Total Comprehensive Income-47.5-134.5-80.4-66.0
Net Income to Common-46.9-134.8-80.9-66.6
Minority Interest0.00.00.00.0
Per Share
Basic EPS-23.93-68.71-37.79-30.27
Diluted EPS-23.93-68.71-37.79-30.26
Other Comprehensive Income — detail
+ Other Comprehensive Income0.20.50.5
+ Items NOT to be Reclassified to P&L-0.80.20.60.7
+ Tax on Items NOT to be Reclassified0.10.20.2
+ Tax on Items NOT to be Reclassified — alt tag-0.2
+ Items to be Reclassified to P&L-0.0
+ Tax on Items to be Reclassified-0.0
Comprehensive Income — Owners of Parent-47.5-134.6-80.5-66.1
Comprehensive Income — Non-controlling Interests0.00.00.00.0
Per Share — as-filed variants
Basic EPS — Continuing Operations-23.93-68.71-37.79-30.27
Diluted EPS — Continuing Operations-23.93-68.71-37.79-30.26
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit138.984.4149.7163.5
Gross Margin %30.3222.1333.4137.10
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)-61.7-141.0-78.9-64.6
− Exceptional Items (reconciliation)0.00.0-2.1-2.1
Net Income Adj (tax-effected)-46.9-134.7-78.8-64.5
EPS Adj-23.93-68.71-36.81-29.32
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value10.000.0010.0010.00
Filed Debt Equity0.010.01
Filed Dscr0.000.00
Filed Iscr0.010.00
Paid Up Equity Capital19.60.022.322.3
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.